Why Get Genetic Testing for Charcot-Marie-Tooth (CMT)?

It is completely understandable to question the value of genetic testing when Charcot-Marie-Tooth disease (CMT) currently has no cure. However, getting a confirmed genetic diagnosis is a crucial step in your medical journey. Genetic testing does more than just give your condition a name; it confirms your diagnosis by ruling out similar, treatable conditions, provides clear answers for your family’s future, and opens the door to emerging, subtype-specific treatments and clinical trials.

Ruling Out Treatable Conditions

CMT shares many symptoms—such as muscle weakness, numbness, and nerve damage—with other peripheral neuropathies. One of the most important reasons to get a genetic test is to make sure you do not actually have an acquired, treatable condition like Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

CIDP is an autoimmune disorder that causes inflammation and attacks the nerves, and its symptoms can look nearly identical to certain types of CMT ^[1][2]. Because the symptoms are so similar, it is not uncommon for CMT to be mistaken for CIDP. This misdiagnosis can lead to patients receiving unnecessary and unhelpful treatments, such as intravenous immunoglobulin (IVIG) or high-dose steroids, which come with their own risks and side effects ^[3]. A definitive genetic diagnosis of CMT confirms that the neuropathy is hereditary and ensures you avoid the physical toll and costs of incorrect medical treatments ^[2][3].

Providing Exact Risks for Family Planning

CMT is a hereditary condition, meaning it is passed down through families. However, how it is passed down depends entirely on the specific genetic mutation you have. CMT has many different inheritance patterns—some types require a mutated gene from only one parent (autosomal dominant), others require one from both parents (autosomal recessive), and some are linked to the X chromosome ^[4][5].

Without a specific genetic diagnosis, doctors can only estimate the likelihood of you passing the condition on to your children. Identifying your exact genetic subtype allows a genetic counselor to give you precise recurrence risks ^[6][7]. If you are planning to start a family, this knowledge gives you access to reproductive options, such as pre-implantation genetic testing for monogenic disorders (PGT-M). PGT-M allows doctors to screen embryos for your specific CMT mutation during in vitro fertilization (IVF), making it possible to select unaffected embryos for pregnancy ^[8][9]. Additionally, finding your specific mutation makes it much easier and less expensive for other at-risk family members to get tested, a process known as cascade testing ^[10].

Determining Eligibility for Clinical Trials and Gene Therapies

While there is currently no general cure for CMT, the landscape of medical research is rapidly changing. Emerging treatments and gene therapies are highly targeted; they do not treat CMT as a whole, but rather focus on repairing or compensating for specific genetic mutations ^[11][12].

For example, a treatment designed for CMT1A will only work for patients who have the specific duplication of the PMP22 gene. If a clinical trial opens for a promising new treatment, researchers will only enroll patients who have a confirmed genetic diagnosis matching the therapy being tested ^[13][14]. Knowing your exact genetic mutation ensures that when a clinical trial or future gene therapy becomes available for your subtype, you are immediately eligible to be evaluated for participation ^[11]. Knowing your genetic subtype also helps your doctor better predict how your symptoms might progress and warns them of certain medications that are known to be toxic to nerves in people with specific forms of CMT ^[15][16].

Understanding the Testing Process and Managing Expectations

Genetic testing usually involves a simple blood draw or cheek swab, which is sent to a specialized lab. The results typically take a few weeks to come back ^[17].

While testing is incredibly valuable, it is important to know that it does not always provide a clear answer right away. Current genetic tests successfully find the mutation in roughly 60% to 70% of people with CMT ^[18]. You might receive a negative result (no mutation found) or a Variant of Uncertain Significance (VUS), which means a change was found in your DNA, but scientists do not yet know if it causes CMT ^[19][20]. A negative result does not mean you do not have CMT; it simply means your specific mutation might be in a gene that researchers have not discovered yet ^[4].

If you are concerned about the cost of testing, ask your neurologist for a referral to a genetic counselor. Genetic counselors specialize in helping you understand which tests are appropriate, explaining the results, and navigating health insurance coverage or finding sponsored testing programs that might significantly reduce your out-of-pocket costs ^[10].